Eko Low Ejection Fraction Tool (ELEFT) vs Rhythm360
AI Verdict
Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko Low Ejection Fraction Tool (ELEFT) if your primary goal is to quickly and non-invasively screen for low ejection fraction during routine physical exams. This tool is ideal for clinicians, including those in primary care, who need an FDA-cleared AI solution integrated with a digital stethoscope to aid in the early identification of heart failure risk at the point of care.
View Eko Low Ejection Fraction Tool (ELEFT) →Choose Rhythm360 if…
Choose Rhythm360 if you require a comprehensive, AI-powered platform to unify and manage cardiac monitoring data from diverse devices across your patient population. This solution is best suited for cardiology practices aiming to reduce alert fatigue, gain actionable insights for complex conditions like heart failure and arrhythmias, and streamline administrative tasks like EHR integration and automated billing for remote patient monitoring.
View Rhythm360 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | Rhythm360 |
|---|---|---|
| Pricing | Unknown | Flexible pricing model that scales with clinic size and platform usage. |
| Deployment | Unknown | Cloud-based SaaS platform |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Unknown |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rhythm360Rhythm360 explicitly prioritizes user experience by offering an all-in-one web application and mobile app designed to unify diverse cardiac data, reduce alert fatigue, and streamline administrative tasks for cardiologists. While ELEFT offers quick, non-invasive detection during a routine exam, Rhythm360's broader scope and focus on simplifying complex workflows across multiple devices and administrative functions suggest a more comprehensive usability advantage for its target users.
Clinical Value
Rhythm360While ELEFT provides significant clinical value through FDA-cleared, early, non-invasive detection of low ejection fraction, Rhythm360 demonstrates a broader and more direct measurable clinical impact across multiple cardiac conditions. Its AI-powered platform has shown an 80% faster response time for critical alerts and a 74% reduction in hospitalizations for heart failure patients through optimized Guideline-Directed Medical Therapy, directly improving patient outcomes and safety.
Pricing & Value
Rhythm360While both tools require contacting sales for specific pricing, Rhythm360 explicitly highlights a flexible, scalable SaaS model and demonstrates clear financial value through automated CPT code documentation and billing, leading to reported revenue increases of up to 300%. ELEFT's pricing is less transparent, though CMS has established a payment rate for its platform, indicating a path to reimbursement.
Enterprise Readiness
Rhythm360Rhythm360 demonstrates superior enterprise readiness due to its comprehensive vendor-neutral data aggregation from all major cardiac device OEMs and robust bi-directional EHR integration with leading systems. This extensive interoperability, combined with automated billing and compliance features, positions it as a more adaptable and integrated solution for large healthcare enterprises.
Innovation
Rhythm360While ELEFT innovates by embedding AI-powered early heart failure detection into a routine stethoscope exam, Rhythm360 offers a broader and more complex suite of innovations. Its vendor-neutral data aggregation from all major OEMs, AI-driven alert triage that significantly reduces response times and fatigue, predictive algorithms for GDMT optimization, and automated billing demonstrate a more comprehensive and impactful approach to modern cardiac care management.
Support & Docs
Rhythm360Rhythm360 offers a higher level of direct support through its optional 24/7/365 oversight by certified cardiac technicians, providing continuous expert monitoring. While Eko Health provides standard documentation and a help center, Rhythm360's integrated human oversight alongside its knowledge base represents a more robust and proactive support model.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Eko Low Ejection Fraction Tool (ELEFT) | Rhythm360 |
|---|---|---|
| Tool Name | Eko Low Ejection Fraction Tool (ELEFT) | Rhythm360 |
| Company | Eko Health | RhythmScience |
| Primary Function | FDA-cleared AI algorithm that integrates with Eko digital stethoscopes to aid clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. | AI-powered integrated platform that unifies cardiac monitoring data from various devices, providing actionable insights for hypertension, heart failure, and rhythm management, and reducing alert fatigue. |
| Key Integrations | Eko digital stethoscopes. | Vendor-neutral data aggregation (all major OEMs: Medtronic, Boston Scientific, Abbott, Biotronik); Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity). |
| Supported Specialties | Cardiology, Family Medicine, Internal Medicine | Cardiology |
| Unique Feature | AI-powered low ejection fraction detection; analyzes ECG and heart sound recordings; provides results in approximately 15 seconds. | Vendor-neutral data aggregation; AI-driven alert triage (80% faster response times); Automated CPT code documentation and billing; Optional 24/7/365 oversight by certified cardiac technicians (CCTs). |
Videos
Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and Rhythm360.
Frequently Asked Questions
More Comparisons
More matchups featuring Eko Low Ejection Fraction Tool (ELEFT) or Rhythm360
Backers
Who funded each tool's parent company.